Maximus, Inc. (NYSE:MMS) Shares Sold by Nuveen Asset Management LLC

Nuveen Asset Management LLC trimmed its position in Maximus, Inc. (NYSE:MMS - Free Report) by 67.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 277,944 shares of the health services provider's stock after selling 570,672 shares during the period. Nuveen Asset Management LLC owned approximately 0.49% of Maximus worth $20,749,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MMS. UMB Bank n.a. grew its position in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares during the last quarter. V Square Quantitative Management LLC grew its position in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares during the last quarter. R Squared Ltd purchased a new position in Maximus in the 4th quarter valued at $54,000. IFP Advisors Inc grew its position in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its position in Maximus by 109.2% in the 4th quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after buying an additional 428 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Maximus Price Performance

Shares of NYSE MMS traded up $2.21 during trading on Tuesday, hitting $74.61. 395,575 shares of the company were exchanged, compared to its average volume of 561,827. The company has a market cap of $4.20 billion, a price-to-earnings ratio of 16.05 and a beta of 0.61. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The firm's fifty day moving average price is $69.44 and its 200 day moving average price is $71.91. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The business's revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.57 EPS. On average, sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.61%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is presently 23.86%.

Insider Transactions at Maximus

In other news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.